查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555024

全球計算生物學市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Computational Biology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

全球計算生物學市場需求預計將從 2023 年的 63.6 億美元達到近 203 億美元的市場規模，2024-2032 年研究期間複合年成長率為 13.76%。

計算生物學是一個跨學科領域，利用計算技術來理解和建模生物系統和過程。它涉及開發和應用演算法、數學模型和軟體工具來分析複雜的生物資料，例如基因組序列、蛋白質結構和細胞相互作用。該領域對於解釋大規模生物資料集、促進基因組學、蛋白質組學和系統生物學的進步至關重要。這有助於發現新的藥物標靶、設計個人化醫療策略以及深入了解疾病的分子機制。將計算方法與生物學研究相結合，支持基礎科學和應用科學的進步，推動藥物發現、醫學診斷和治療開發的創新。

市場動態

基因組學和蛋白​​質組學研究產生的生物資料呈指數級成長，推動了計算生物學市場的發展，這需要複雜的計算工具來管理和分析這些資訊。個人化醫療和標靶治療的日益普及推動了對預測患者特異性治療反應的先進計算模型的需求。此外，人工智慧和機器學習的進步正在增強計算生物學工具的能力，從而可以更準確地預測和洞察複雜的生物系統。政府和私營部門對生物技術和醫療保健研究投資的增加進一步推動了市場成長。研究機構和技術公司之間的合作也促進了計算生物學應用的創新。此外，對高效藥物發現和開發流程的需求為計算方法簡化這些活動創造了機會，從而加快了醫學進步的步伐。然而，先進計算工具的高成本以及整合不同生物資料的複雜性可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球計算生物學市場的每個細分市場進行了包容性評估。計算生物學產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

計算生物學市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按服務

  • 資料庫
  • 基礎設施和硬體
  • 軟體平台

按申請

  • 藥物發現與疾病建模（標靶辨識、標靶驗證、先導化合物發現、先導化合物最佳化）
  • 臨床前藥物開發（藥物動力學、藥效學）
  • 臨床試驗（一期、二期、三期、四期）
  • 計算基因組學
  • 計算蛋白質體學
  • 其他

按最終用途

  • 學術與研究
  • 工業的

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲計算生物學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。計算生物學市場的主要參與者包括 DNAnexus、Illumina、Thermo Fisher Scientific、Schrodinger、Compugen、Aganitha AI Inc.、Genedata AG、Qiagen、Simulations Plus Inc. Fios Genomics。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：計算生物學 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按服務分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球計算生物市場分析：按服務分類

  • 按服務概覽
  • 按服務進行歷史和預測資料分析
  • 資料庫
  • 基礎設施和硬體
  • 軟體平台

第 6 章：全球計算生物學市場分析：依應用分類

  • 概述：按應用
  • 歷史與預測資料分析：按應用分類
  • 藥物發現與疾病建模（標靶辨識、標靶驗證、先導化合物發現、先導化合物最佳化）
  • 臨床前藥物開發（藥物動力學、藥效學）
  • 臨床試驗（一期、二期、三期、四期）
  • 計算基因組學
  • 計算蛋白質體學
  • 其他

第 7 章：全球計算生物市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 學術與研究
  • 工業的

第 8 章：全球計算生物學市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：計算生物公司的競爭格局

  • 計算生物學市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • DNAnexus
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Illumina
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Schrodinger
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Compugen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Aganitha AI Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Genedata AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Qiagen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Simulations Plus Inc. Fios Genomics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115581

The global demand for Computational Biology Market is presumed to reach the market size of nearly USD 20.3 Billion by 2032 from USD 6.36 Billion in 2023 with a CAGR of 13.76% under the study period 2024-2032.

Computational biology is an interdisciplinary field that utilizes computational techniques to understand and model biological systems and processes. It involves developing and applying algorithms, mathematical models, and software tools to analyze complex biological data, such as genomic sequences, protein structures, and cellular interactions. This field is essential for interpreting large-scale biological datasets, enabling genomics, proteomics, and systems biology advancements. This facilitates the discovery of new drug targets, the design of personalized medicine strategies, and the insight into the molecular mechanisms of diseases. Integrating computational methods with biological research supports the advancement of both basic and applied sciences, driving innovation in drug discovery, medical diagnostics, and therapeutic development.

MARKET DYNAMICS

The computational biology market is propelled by the exponential growth in biological data generated from genomics and proteomics research, which necessitates sophisticated computational tools to manage and analyze this information. The increasing adoption of personalized medicine & targeted therapies drives demand for advanced computational models that predict patient-specific treatment responses. Moreover, advancements in artificial intelligence & machine learning are enhancing the capabilities of computational biology tools, allowing for more accurate predictions & insights into complex biological systems. The rise in government and private sector investments in biotechnology and healthcare research further fuels market growth. Collaborations between research institutions and technology companies also foster innovation in computational biology applications. Additionally, the need for efficient drug discovery and development processes creates opportunities for computational approaches to streamline these activities, thereby accelerating the pace of medical advancements. However, the high cost of advanced computational tools and the complexity of integrating diverse biological data may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Computational Biology. The growth and trends of Computational Biology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Computational Biology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Databases
  • Infrastructure & Hardware
  • Software Platform

By Application

  • Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization)
  • Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics)
  • Clinical Trial (Phase I, Phase II, Phase III, Phase IV)
  • Computational Genomics
  • Computational Proteomics
  • Others

By End-use

  • Academic & Research
  • Industrial

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Computational Biology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Computational Biology market include DNAnexus, Illumina, Thermo Fisher Scientific, Schrodinger, Compugen, Aganitha AI Inc., Genedata AG, Qiagen, Simulations Plus Inc. Fios Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COMPUTATIONAL BIOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY SERVICE

  • 5.1. Overview By Service
  • 5.2. Historical and Forecast Data Analysis By Service
  • 5.3. Databases Historic and Forecast Sales By Regions
  • 5.4. Infrastructure & Hardware Historic and Forecast Sales By Regions
  • 5.5. Software Platform Historic and Forecast Sales By Regions

6. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Historic and Forecast Sales By Regions
  • 6.4. Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Historic and Forecast Sales By Regions
  • 6.5. Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Historic and Forecast Sales By Regions
  • 6.6. Computational Genomics Historic and Forecast Sales By Regions
  • 6.7. Computational Proteomics Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Academic & Research Historic and Forecast Sales By Regions
  • 7.4. Industrial Historic and Forecast Sales By Regions

8. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE COMPUTATIONAL BIOLOGY COMPANIES

  • 9.1. Computational Biology Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF COMPUTATIONAL BIOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. DNAnexus
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Illumina
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Thermo Fisher Scientific
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Schrodinger
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Compugen
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Aganitha AI Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Genedata AG
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Qiagen
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Simulations Plus Inc. Fios Genomics
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service (USD MN)
  • Databases Market Sales By Geography (USD MN)
  • Infrastructure & Hardware Market Sales By Geography (USD MN)
  • Software Platform Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Market Sales By Geography (USD MN)
  • Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Market Sales By Geography (USD MN)
  • Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Market Sales By Geography (USD MN)
  • Computational Genomics Market Sales By Geography (USD MN)
  • Computational Proteomics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Academic & Research Market Sales By Geography (USD MN)
  • Industrial Market Sales By Geography (USD MN)
  • Global Computational Biology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Computational Biology Report
  • Market Research Process
  • Market Research Methodology
  • Global Computational Biology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Service (USD MN)
  • Databases Market Sales By Geography (USD MN)
  • Infrastructure & Hardware Market Sales By Geography (USD MN)
  • Software Platform Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Market Sales By Geography (USD MN)
  • Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Market Sales By Geography (USD MN)
  • Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Market Sales By Geography (USD MN)
  • Computational Genomics Market Sales By Geography (USD MN)
  • Computational Proteomics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Academic & Research Market Sales By Geography (USD MN)
  • Industrial Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.